Cardiology Xagena
A two-year study demonstrated that Rosuvastatin ( Crestor ) reversed plaque build-up in the arteries of patients with evidence of coronary artery disease.
This is the first time a statin has demonstrated regression of atherosclerosis in a major clinical study.
Data showed that plaque build-up in patientsarteries was reduced by between seven and nine per cent.
These significant changes were achieved with Rosuvastatin and were associated with significant reductions in LDL cholesterol ( LDL-C ) ( 53 per cent, p
